(Q50106768)
Statements
1 reference
Randomized, double-blind, placebo-controlled dose-ranging study of tirofiban (MK-383) platelet IIb/IIIa blockade in high risk patients undergoing coronary angioplasty. (English)
1 reference
Kereiakes DJ
1 reference
Weaver WD
1 reference
Kleiman NS
1 reference
Ambrose J
1 reference
Cohen M
1 reference
Rodriguez S
1 reference
Palabrica T
1 reference
Herrmann HC
1 reference
Sutton JM
1 reference
McKee DB
1 reference
Fitzpatrick V
1 reference
Sax FL
1 reference
1 March 1996
1 reference
27
1 reference
3
1 reference
536-542
1 reference
Identifiers
1 reference
1 reference